The Deal:
In February, we successfully completed the sale of Amerifit Brands, Inc. to Martek Biosciences Corporation (NASDAQ:MATK) in a transaction valued at $200 million. The transaction followed a period of significant growth for Amerifit, driven by numerous initiatives undertaken by Charterhouse to build and strengthen the Company's portfolio of premier health and wellness brands. Today, Amerifit holds strong market positions in the Women's Health category with the following key brands: CulturelleŽ, a leading probiotic supplement; AZOŽ, the leading OTC brand addressing symptom relief, detection and prevention of urinary tract infections; and ESTROVENŽ, the leading all-natural nutritional supplement brand addressing the symptoms of menopause. Amerifit's products are sold in most major mass, club, drug, grocery and specialty stores.
Our original investment, which was made in 2005, was the result of a targeted search overseen by Charterhouse Entrepreneur Paul Mullan (who served as Chairman). Under Charterhouse's ownership, the Company significantly grew its revenue base and more than doubled EBITDA through two add-on acquisitions, new product introductions and organic growth achieved through numerous product extensions.
|